Cancer Therapy : Preclinical Dual Targeting of Wild-Type and Mutant p 53 by Small Molecule RITA Results in the Inhibition of N-Myc and Key Survival Oncogenes and Kills Neuroblastoma Cells In Vivo and In Vitro